Skip to main content
. 2015 Mar 16;6(11):9125–9139. doi: 10.18632/oncotarget.3273

Table 1. Correlation between the expression level of miR-155 with clinicopathological features.

Clinicopathological features Low miR-155 High miR-155 Total P-value
Gender
 Male  9  9 18 0.692
 Female  2  3  5
Age
 ≥ 63  6  6 12 0.827
 < 62  5  6 11
Location
 Sacrum 10 10 20 0.59
 Other  1  2  3
Stage
 1A + 1B  9  4 13 0.036a
 2A + 2B + 3  2  8 10
Origin
 Primary origin  8  4 12 0.059
 Recurrent origin  3  8 11
Local recurrence
 Overall
  Yes  5  6 11 0.827
  No  6  6 12
 Primary origin
  Yes  3  0  3 0.157
  No  5  4  9
 Recurrent origin
  Yes  2  6  8 0.782
  No  1  2  3
Metastasis
 Yes  0  4  4 0.035a
 No 11  8 19

The relationships of the high and low expression group of miR-155 with clinicopathological features of chordoma patients were analyzed by chi-squared test.

a

Indicates statistical significance. Statistical significance was defined as a P-value of < 0.05.